ARTICLE | Management Tracks
Goldstein becomes president and CMO at Aurion
Plus Duke to be CFO at Apexigen and updates from MC2, Pillar, Nonagen and more
June 9, 2022 9:44 PM UTC
Ophthalmology cell therapy company Aurion Biotechnologies hired Michael Goldstein as president and CMO. Goldstein previously served as president and CMO of Ocular Therapeutix Inc. (NASDAQ:OCUL) and as CMO of Applied Genetic Technologies Corp. (NASDAQ:AGTC).
Apexigen Inc. hired William Duke as CFO. Duke joins the company from Kaleido Biosciences Inc. (NASDAQ:KLDO), where he was also CFO. Previously, he was CFO of Pulmatrix Inc. (NASDAQ:PULM) and Valeritas Inc. Apexigen is developing antibody therapies to treat cancer. ...